Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue

被引:13
作者
Dantas, Wagner Silva [1 ]
Gualano, Bruno [1 ]
Rocha, Michele Patrocinio [2 ]
Grimaldi Barcellos, Cristiano Roberto [2 ]
Vieira Yance, Viviane dos Reis [2 ]
Miguel Marcondes, Jose Antonio [2 ]
机构
[1] Univ Sao Paulo, Sch Phys Educ & Sport, Lab Appl Nutr & Metab, BR-05508030 Sao Paulo, Brazil
[2] Univ Sao Paulo, Div Endocrinol, Sch Med, BR-05508030 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
POLYCYSTIC-OVARY-SYNDROME; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; ANDROGEN EXCESS; ADIPOSE-TISSUE; WOMEN; PREVALENCE; TRANSPORT; PIOGLITAZONE; MECHANISMS;
D O I
10.1155/2013/178364
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Polycystic ovary syndrome is a complex hormonal disorder affecting the reproductive and metabolic systems with signs and symptoms related to anovulation, infertility, menstrual irregularity and hirsutism. Skeletal muscle plays a vital role in the peripheral glucose uptake. Since PCOS is associated with defects in the activation and pancreatic dysfunction of beta-cell insulin, it is important to understand the molecular mechanisms of insulin resistance in PCOS. Studies of muscle tissue in patients with PCOS reveal defects in insulin signaling. Muscle biopsies performed during euglycemic hyperinsulinemic clamp showed a significant reduction in glucose uptake, and insulin-mediated IRS-2 increased significantly in skeletal muscle. It is recognized that the etiology of insulin resistance in PCOS is likely to be as complicated as in type 2 diabetes and it has an important role in metabolic and reproductive phenotypes of this syndrome. Thus, further evidence regarding the effect of nonpharmacological approaches (e.g., physical exercise) in skeletal muscle of women with PCOS is required for a better therapeutic approach in the management of various metabolic and reproductive problems caused by this syndrome.
引用
收藏
页数:7
相关论文
共 57 条
[1]   Pathogenesis of Insulin Resistance in Skeletal Muscle [J].
Abdul-Ghani, Muhammad A. ;
DeFronzo, Ralph A. .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
[2]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[3]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[4]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[5]   Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects [J].
Bandyopadhyay, Gautam K. ;
Yu, Joseph G. ;
Ofrecio, Jachelle ;
Olefsky, Jerrold M. .
DIABETES, 2006, 55 (08) :2277-2285
[6]   Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome [J].
Barcellos, Cristiano R. G. ;
Rocha, Michelle P. ;
Hayashida, Sylvia A. Y. ;
Nery, Marcia ;
Marcondes, Jose A. M. .
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (04) :601-605
[7]   The effects of old, new and emerging medicines on metabolic aberrations in PCOS [J].
Bargiota, Alexandra ;
Diamanti-Kandarakis, Evanthia .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (01) :27-47
[8]   Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance [J].
Blaak, EE .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (03) :391-403
[9]   Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome [J].
Brettenthaler, N ;
De Geyter, C ;
Huber, PR ;
Keller, U .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :3835-3840
[10]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25